Back

Glucagon-like peptide 1 based treatments preserve left ventricular diastolic function irrespective of body weight changes - a systematic review and meta-analysis

30 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Progress in HFmrEF and HFpEF Diastolic Ventricular Dysfunction ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Tien Dung Nguyen

University hospital Jena, Jena (Germany)

8 More presentations in this session

Presentation thumbnail
Worsening heart failure after primary catheter ablation in patients with atrial fibrillation with preserved ejection fraction: predictive value of HFA-PEFF score and H2FPEF score
Doctor S. Hirayama (Niigata, JP)
Abstract Slides Video
Presentation thumbnail
Absence of causal association between NAFLD and heart failure: mendelian randomization evidence"
Mr S. Huang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Quality of life and symptom burden among patients with heart failure with preserved ejection fraction (HFpEF): variations by BMI categories
Mr N. Upadhyay (Indianapolis, US) Doctor A. Plat (NL)
Abstract Slides Video
Presentation thumbnail
Diastolic dysfunction as a predictor of postoperative heart failure in non-cardiac surgery
Doctor S. Gefen (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Prognosis of left ventricular dilatation in HFmrEF
Doctor H. Steffen (Mannheim, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Progress in HFmrEF and HFpEF

The Event

Event poster

ESC Congress 2025

30 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 receptor agonists for obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
30 August 2025
thumbnail
Congress Presentation
GLP1 receptor agonists exhibit antioxidant and anti-inflammatory properties in human heart tissue via the canonical GLP1 receptor expression through a AMPK-mediated pathway
28 August 2023
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists improve indices of atrial cardiomyopathy: a systematic review and meta-analysis
1 April 2025
thumbnail
Congress Presentation
Empagliflozin improves diastolic function in obese ZSF1 rats by restoring the cardiac mitochondrial respiratory capacity.
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources